{"news_desk": "OpEd", "print_page": "27", "section_name": "Opinion", "subsection_name": null, "document_type": "article", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2015/01/13/opinion/13Lipska/13Lipska-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2015/01/13/opinion/13Lipska/13Lipska-thumbWide.jpg"}, {"height": 681, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "681", "xlarge": "images/2015/01/13/opinion/13Lipska/13Lipska-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2015/01/13/opinion/13Lipska/13Lipska-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/01/13/opinion/13Lipska/13Lipska-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2015/01/13/opinion/13Lipska/13Lipska-thumbStandard.jpg"}], "abstract": "Op-Ed article by endocrinologist Kasia Lipska warns treatment for Type 2 diabetes among elderly Americans may be too aggressive, putting them at risk of severe hypoglycemia, bad drug interactions and other complications; contends influence of drug industry may be partly to blame for problem; calls for elimination of catch-all blood sugar target of 7 in favor of case-by-case evaluation of patients.", "type_of_material": "Op-Ed", "word_count": "839", "lead_paragraph": "Plunging blood sugar levels put older patients at risk.", "pub_date": "2015-01-12T00:00:00Z", "_id": "54b3f26738f0d82eb90f225b", "byline": {"contributor": "", "original": "By KASIA LIPSKA", "person": [{"rank": 1, "role": "reported", "firstname": "Kasia", "organization": "", "lastname": "LIPSKA"}]}, "source": "The New York Times", "snippet": "Plunging blood sugar levels put older patients at risk.", "web_url": "http://www.nytimes.com/2015/01/12/opinion/when-diabetes-treatment-goes-too-far.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "Y", "value": "Diabetes", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Elderly", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "headline": {"main": "When Diabetes Treatment Goes Too Far", "content_kicker": "Op-Ed Contributor", "print_headline": "When Diabetes Treatment Goes Too Far", "kicker": "Op-Ed Contributor"}}